| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | EVP, Chief Strategy Officer | Common Stock, $0.01 par value | 53.5K | $8.28M | $154.72 | May 16, 2022 | In trust |
| AbbVie Inc. | EVP, Chief Strategy Officer | Common Stock, $0.01 par value | 41.6K | $6.44M | $154.72 | May 16, 2022 | Direct |
| Neumora Therapeutics, Inc. | President & CEO, Director | Common Stock | 462K | $5.54M | $11.98 | Feb 14, 2024 | Direct |
| Neumora Therapeutics, Inc. | President & CEO, Director | Common Stock | 127K | $1.53M | $11.98 | Feb 14, 2024 | Indirect |
| AbbVie Inc. | EVP, Chief Strategy Officer | Common Stock, $0.01 par value | 3.64K | $563K | $154.72 | May 16, 2022 | Profit sharing trust |
| Neumora Therapeutics, Inc. | President & CEO, Director | Stock Option (Right to Buy) | 160K | Feb 14, 2024 | Direct | ||
| ACELYRIN, Inc. | Director | Director Stock Option (right to buy) | 92.2K | Jun 7, 2024 | Direct | ||
| Aptinyx Inc. | Director | Stock Option (Right to Buy) | 40K | May 26, 2022 | Direct | ||
| AbbVie Inc. | EVP, Chief Strategy Officer | Option (Right to Buy) | 0 | $144.54 | May 16, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SLRN | ACELYRIN, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| NMRA | Neumora Therapeutics, Inc. | Feb 14, 2024 | 2 | $0 | 4 | Feb 16, 2024 | President & CEO, Director |
| NMRA | Neumora Therapeutics, Inc. | Sep 19, 2023 | 1 | $189K | 4 | Sep 19, 2023 | President & CEO, Director |
| NMRA | Neumora Therapeutics, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | President & CEO, Director |
| SLRN | ACELYRIN, Inc. | May 9, 2023 | 3 | $900K | 4 | May 11, 2023 | Director |
| SLRN | ACELYRIN, Inc. | May 4, 2023 | 0 | $0 | 3 | May 4, 2023 | Director |
| APTX | Aptinyx Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
| ABBV | AbbVie Inc. | May 16, 2022 | 3 | -$13M | 4/A | May 20, 2022 | EVP, Chief Strategy Officer |
| ABBV | AbbVie Inc. | Mar 1, 2022 | 4 | -$3.68M | 4/A | May 20, 2022 | EVP, Chief Strategy Officer |
| ABBV | AbbVie Inc. | Feb 25, 2022 | 4 | -$6.73M | 4 | Mar 1, 2022 | EVP, Chief Strategy Officer |
| ABBV | AbbVie Inc. | Feb 17, 2022 | 5 | $0 | 4 | Feb 22, 2022 | EVP, Chief Strategy Officer |
| ABBV | AbbVie Inc. | Sep 7, 2021 | 2 | $0 | 4 | Sep 10, 2021 | EVP, Chief Strategy Officer |
| APTX | Aptinyx Inc. | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |